|
Characterization of subjects taking statins or in comparator groups. |
||||||||
| Drug Name |
No. of cases |
Age |
Average Charlson Index |
Average no. of hospital stays |
Cases (%) |
|||
|
|
||||||||
| Mean |
SD |
Mean |
SD |
Mean |
SD |
|||
|
|
||||||||
| CV |
394 739 |
74.6 |
5.7 |
2.0 |
2.0 |
0.5 |
1.5 |
30.6 |
| Warfarin |
53 369 |
75.9 |
5.7 |
2.6 |
2.3 |
0.8 |
1.9 |
4.1 |
| Atorvastatin |
53 869 |
73.5 |
5.3 |
2.3 |
2.2 |
0.6 |
1.6 |
4.2 |
| Fluvastatin |
5 136 |
74.2 |
5.6 |
2.0 |
2.1 |
0.4 |
1.2 |
0.4 |
| Lovastatin |
54 052 |
74.8 |
5.6 |
2.1 |
2.1 |
0.4 |
1.4 |
4.2 |
| Pravastatin |
1 778 |
73.5 |
5.3 |
2.4 |
2.4 |
0.5 |
1.4 |
0.1 |
| Simvastatin |
727 128 |
74.5 |
5.6 |
2.0 |
2.0 |
0.4 |
1.3 |
56.4 |
| Total |
1 290 071 |
74.6 |
5.6 |
2.1 |
2.0 |
0.4 |
1.4 |
100.0 |
|
Column 1, medication group; column 2, the number of subjects ≥65 years who exhibited continuous use of statins for at least 7 months; columns 3 and 4, mean age and standard deviation (SD); columns 5 and 6, Charlson Index and SD; columns 7 and 8, hospitalization rate and SD; column 9, percentage of cases in each group. | ||||||||
Wolozin et al. BMC Medicine 2007 5:20 doi:10.1186/1741-7015-5-20 |
||||||||